Drugs / Malathion
Malathion
also known as
8059HC · Cythion · Derbac-m · ENT 17,034 · MALG · NSC-6524 · Organoderm · Ovide · +4 more
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | OVIDE | — | 1982-08-02 | fda.gov ↗ |
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00927407 | Jul → Aug 2009 | Pediculus humanus capitis infestation | Sun Pharmaceutical Industries, Inc. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00291057 | Feb → Oct 2006 | lice infestation | Sun Pharmaceutical Industries, Inc. | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00752973 | Sep 2008 → Dec 2011 | Pediculus humanus capitis infestation | Sun Pharmaceutical Industries, Inc. | Completed | No outcome recorded |
| Phase 32 trials · 2 met primary | ||||||
| Phase 3 | NCT00963508 | Aug 2009 → Mar 2010 | lice infestation | Sun Pharmaceutical Industries, Inc. | Completed | Met primary |
| Phase 3 | NCT00927472 | Aug 2009 → May 2010 | Pediculus humanus capitis infestation | Sun Pharmaceutical Industries, Inc. | Completed | Met primary |
| Comparator or background therapy4 trials | ||||||
| Phase 2 | NCT02213055 Comparator | May 2009 → Aug 2014 | Pediculus humanus capitis infestation | Hackensack Meridian Health | Completed | No outcome recorded |
| Phase 3 | NCT03236168 Background | Aug → Dec 2017 | Pediculus humanus capitis infestation, scabies | London School of Hygiene and Tropical Medicine | Completed | No outcome recorded |
| Phase 3 | NCT00244439 Comparator | Dec 2005 → Oct 2006 | Pediculus humanus capitis infestation | Sun Pharmaceutical Industries, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00819520 Comparator | Feb → Sep 2004 | lice infestation | Johnson & Johnson Consumer and Personal Products Worldwide | Completed | Met primary |
Evidence & citations 15 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Malathion | “a novel formulation of malathion 0.5% was evaluated in patients 2 years of age and older” NCT00291057 ↗ |
| Known as | 8059HC | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200468 ↗ |
| Known as | Cythion | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200468 ↗ |
| Known as | Derbac-m | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200468 ↗ |
| Known as | ENT 17,034 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200468 ↗ |
| Known as | MALG | “MALG (malathion) Treatment” NCT00752973 ↗ |
| Known as | NSC-6524 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200468 ↗ |
| Known as | Organoderm | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200468 ↗ |
| Known as | Ovide | “Ovide (malathion) lotion 0.05%” NCT00244439 ↗ |
| Known as | Ovide Lotion | “0.5% malathion gel versus Ovide Lotion (0.5% malathion) or Nix Crème Rinse (1% permethrin) used as labeled, for the treatment of head lice.” PMID 17845167 ↗ Jul 2007 |
| Known as | Prioderm | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200468 ↗ |
| Known as | Quellada-m | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200468 ↗ |
| Known as | Suleo-m | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200468 ↗ |
| Modality | Small molecule | — CHEMBL1200468 ↗ |
| Route | Topical | “Two single applications of malathion 0.5% lotion (Days 1 and 8)” NCT00819520 ↗ |